AVXS-201

N/A

Report date: 2023/10/26 17:03:12

Base Information

Drug NameAVXS-201
Drug Alias NameAVXS-201AVXS201OAV-201scAAV9.MeCP2
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionMethyl-CpG-binding protein 2 gene replacement
TargetsMethyl-CpG-binding protein 2
Therapy Area/IndicationsRett Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Gene Therapies EU Ltd
Active IndicationsN/A
Inactive IndicationsRett Syndrome

Other Information

ATC CodeN/A
Related LinksN/A